Literature DB >> 7227434

In vitro adriamycin sensitivity test and hormonal receptors in primary breast cancer.

M Kaufmann, K Klinga, B Runnebaum, F Kubli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7227434     DOI: 10.1016/0014-2964(80)90035-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  5 in total

1.  Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study.

Authors:  David Sarid; Ilan G Ron; Fani Sperber; Yona Stadler; Perry Kahan; Felix Kovner; Rami Ben-Yosef; Sylvia Marmor; Yulia Grinberg; Natalie Maimon; Juliana Weinstein; Neora Yaal-Hahoshen
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

2.  Adjuvant chemotherapy and venous thrombosis.

Authors:  M Kaufmann; G Lammers; D Fritze; F Kubli
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

3.  Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer.

Authors:  Joanna Szkandera; Gudrun Absenger; Nadia Dandachi; Peter Regitnig; Sigurd Lax; Michael Stotz; Hellmut Samonigg; Wilfried Renner; Armin Gerger
Journal:  Mol Genet Genomics       Date:  2012-08-18       Impact factor: 3.291

4.  Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer.

Authors:  A E Ring; I E Smith; S Ashley; L G Fulford; S R Lakhani
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

5.  Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids.

Authors:  Kathrin Halfter; Oliver Hoffmann; Nina Ditsch; Mareike Ahne; Frank Arnold; Stefan Paepke; Dieter Grab; Ingo Bauerfeind; Barbara Mayer
Journal:  J Transl Med       Date:  2016-05-03       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.